Filing Details
- Accession Number:
- 0000950170-24-052283
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-02 16:58:17
- Reporting Period:
- 2024-05-01
- Accepted Time:
- 2024-05-02 16:58:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1111485 | Rxsight Inc. | RXST | Ophthalmic Goods (3851) | 943268801 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1297491 | B Shelley Thunen | C/O Rxsight, Inc. 100 Columbia Aliso Viejo CA 92656 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-01 | 10,247 | $15.60 | 23,938 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-01 | 9,620 | $52.68 | 14,318 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-05-01 | 380 | $53.04 | 13,938 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-01 | 10,000 | $0.00 | 10,000 | $15.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 46,805 | 2031-03-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 8,402 | Indirect | See footnote |
Footnotes
- Includes 247 shares of Common Stock acquired April 30, 2024 under the Issuer's 2021 Employee Stock Purchase Plan.
- The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted on September 14, 2023 by the Reporting Person.
- Represents the weighted average share price of an aggregate total of 9,620 shares sold in the price range of $52.00 to $52.99 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 380 shares sold in the price range of $53.00 to $53.14 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Shares held by the Shelley B. Thunen Revocable Family Trust, as Amended, for which the Reporting Person serves as trustee.
- Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 22, 2021.
Billionaire Hedge Funds
